Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00481455
What this trial is testing

Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion (NCD) in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Recurrent Glioblastoma Multiforme
CASI pharmaceuticals, Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT03866109
What this trial is testing

A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT

Who this might be right for
Glioblastoma Multiforme
Genenta Science 25
Testing effectiveness (Phase 2)Looking for participantsNCT06177964
What this trial is testing

Lerapolturev (PVSRIPO) in GBM

Who this might be right for
Recurrent Supratentorial Glioblastoma
Darell Bigner 92
Testing effectiveness (Phase 2)Study completedNCT01062399
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 279
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673787
What this trial is testing

A Trial of Ipatasertib in Combination With Atezolizumab

Who this might be right for
Solid TumorGlioblastoma MultiformeProstate Cancer Metastatic
Institute of Cancer Research, United Kingdom 87
Testing effectiveness (Phase 2)Study completedNCT01204684
What this trial is testing

Dendritic Cell Vaccine for Patients With Brain Tumors

Who this might be right for
GliomaAnaplastic AstrocytomaAnaplastic Astro-oligodendroglioma+1 more
Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07670026
What this trial is testing

Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression

Who this might be right for
Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT00906893
What this trial is testing

Evaluation of [18F]-FMISO for Non Operated Glioblastoma

Who this might be right for
Glioblastoma
University Hospital, Bordeaux 14
Testing effectiveness (Phase 2)Study completedNCT01856933
What this trial is testing

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Who this might be right for
GBMGlioblastoma MultiformeGliosarcoma
Heinrich Elinzano, MD 6
Testing effectiveness (Phase 2)Study completedNCT02364206
What this trial is testing

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Adult Glioblastoma
Centre Jean Perrin 18
Testing effectiveness (Phase 2)Study completedNCT00003751
What this trial is testing

Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Study completedNCT00003301
What this trial is testing

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Ended earlyNCT03705351
What this trial is testing

Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM

Who this might be right for
GlioblastomaCancer of BrainGlioblastoma Multiforme+1 more
Providence Health & Services 7
Not applicableStudy completedNCT01923922
What this trial is testing

CT Perfusion in the Prognostication of Cerebral High Grade Glioma

Who this might be right for
Glioblastoma Multiforme
Nova Scotia Health Authority 48
Testing effectiveness (Phase 2)Looking for participantsNCT05465954
What this trial is testing

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Who this might be right for
High Grade Astrocytic TumorRecurrent Glioblastoma, IDH-WildtypeRecurrent Gliosarcoma
Mayo Clinic 54
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Large-scale testing (Phase 3)Study completedNCT00118222
What this trial is testing

High Light and Low Light Dose PDT in Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Case Comprehensive Cancer Center 1
Not applicableStudy completedNCT05296122
What this trial is testing

Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions

Who this might be right for
Glioblastoma
Clinical Laserthermia Systems AB 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT03581292
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Who this might be right for
Anaplastic AstrocytomaGlioblastomaMalignant Glioma
National Cancer Institute (NCI) 38
Large-scale testing (Phase 3)Study completedNCT02667587
What this trial is testing

An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Who this might be right for
Brain Neoplasms
Bristol-Myers Squibb 716
Next Page